Scholarly publications and presentations by Rochester Regional Health's Infectious Diseases department authors.
Submissions from 2023
2-7-2023 It's Probably Just a Phage: Novel Treatment Strategies in Multi-Drug Resistant Infections, Alexandra Yamshchikov, Rochester Regional Health
2-1-2023 Gene Expression Risk Scores for COVID-19 Illness Severity, Derick R. Peterson, Andrea M. Baran, Edward E. Walsh, Rochester Regional Health, et al.
1-17-2023 AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection, Anastasia A. Aksyuk, Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Himanshu Bansal, Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., Deidre Wilkins, Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA., et al.
1-13-2023 Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated, Jill Maaske, Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Stephanie Sproule, Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Ann R. Falsey, Rochester Regional Health, et al.
Submissions from 2022
12-1-2022 1428. Clinical Characteristics and Management of Nontuberculous Mycobacterial Infections in the Finger Lakes Region of New York, Michael Croix, University of Rochester; Ghinwa Dumyati, University of Rochester Medical Center Division of Infectious Diseases; and Emil P. Lesho, Rochester Regional Health
12-1-2022 1782. Antimicrobial Stewardship Opportunities in Gram-Negative Bacteremia Treatment at a Community Teaching Hospital, Matthew Ficinski, Rochester Regional Health and Maryrose R. Laguio-Vila, Rochester Regional Health
12-1-2022 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination, Magdalena E. Sobieszczyk, New York-Presbyterian Columbia University Irving Medical Center and Ann R. Falsey, Rochester Regional Health
12-1-2022 2208. Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis, John M. McLaughlin, Pfizer, Collegeville, Farid L. Khan, Pfizer, Collegeville, Elizabeth Begier, Pfizer Vaccines, Dublin, et al.
12-1-2022 330. BioFire ® FilmArray® Pneumonia Panel (PN) Results Compared to Standard Microbiologic Testing and Clinical Adjudication in Adults Hospitalized with Respiratory Illness, Ann R. Falsey, Rochester Regional Health, Angela R. Branche, University of Rochester, Maria A. Formica, Rochester Regional Health, et al.
11-10-2022 It’s Probably Just a Phage: Novel Treatment Strategies in Multi-Drug Resistant Infections, Alexandra Yamshchikov, Rochester Regional Health and Scott C. Feitell, Rochester Regional Health
11-1-2022 Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults, Angela R. Branche, Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, New York, USA., Lisa Saiman, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA., Edward E. Walsh, Rochester Regional Health, et al.
11-2022 Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial, Wesley H. Self, Vanderbilt University Medical Center; Allison P. Wheeler, Vanderbilt University Medical Center, Nashville, Tennessee; and Maryrose Laguio-Vila, Rochester Regional Health
9-15-2022 Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months, Magdalena E Sobieszczyk, Columbia University Irving Medical Center, New York, New York, Jill Maaske, AstraZeneca, Gaithersburg, Maryland, Ann R. Falsey, Rochester Regional Health, et al.
9-8-2022 High Consequence Pathogens and HAI* (Healthcare Associated Infection) Priorities: Infectious Disease & Infectious Control Updates for 2022-2023, Emil P. Lesho, Rochester Regional Health
8-30-2022 A Simple Walk in the Park...Or is it? Lyme Disease, Michael Mancenido, Rochester Regional Health
7-19-2022 Monkeypox, Anja Bottler, Rochester Regional Health
6-17-2022 Rates of Medically Attended RSV among US Adults: A Systematic Review and Meta-Analysis, John M. McLaughlin, Pfizer Vaccines, Collegeville, PA, USA, Farid Khan, Pfizer Vaccines, Collegeville, PA, USA, Elizabeth Begier, Pfizer Vaccines, Collegeville, PA, USA, et al.
6-15-2022 Phase 1/2 Randomized Study of the Immunogenicity, Safety and Tolerability of an RSV Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine, Ann R. Falsey, Rochester Regional Health; Edward E. Walsh, Rochester Regional Health; and Daniel A. Scott, Vaccine Research and Development, Pfizer Inc, Collegeville, PA, 19426 USA.
5-15-2022 Go V.I.R.A.L.: Social Media Engagement Strategies in Infectious Diseases, Bradley J. Langford, Public Health Ontario, Toronto, Ontario, Canada., Maryrose Laguio-Vila, Rochester Regional Health, Timothy P. Gauthier, Baptist Health South Florida Clinical Pharmacy Enterprise, Miami, Florida, USA., et al.
4-15-2022 A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine, Edward E. Walsh, Rochester Regional Health; Ann R. Falsey, Rochester Regional Health; and Daniel A. Scott, Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
3-24-2022 Antimicrobial Stewardship Opportunities in Hospitalized Patients with Febrile Neutropenia, Carlos Portales Castillo, Rochester Regional Health and Maryrose R. Laguio-Vila, Rochester Regional Health
3-15-2022 Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2020, Angela R. Branche, University of Rochester; Edward E. Walsh, Rochester Regional Health; and Ann R. Falsey, Rochester Regional Health
3-1-2022 Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York, Emil Lesho, Rochester Regional Health, Brendan Corey, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, Francois Lebreton, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, et al.
1-22-2022 Effectiveness of various cleaning strategies in acute and long-term care facilities during novel corona virus 2019 disease pandemic-related staff shortages, Emil Lesho, Rochester Regional Health, Donna Newhart, Rochester Regional Health, Lisa Reno, Rochester Regional Health, et al.
1-18-2022 COVID-19: Medication Update, Anja Bottler, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health